Cargando…
Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
SIMPLE SUMMARY: Papillary thyroid cancer (PTC) comprises approximately 80% of all thyroid malignancies. The field of PTC genetics and cancerogenesis remains undetermined. Activated mTOR is involved in the development and progression of PTC. We performed a systematic review of papers studying the exp...
Autores principales: | Derwich, Aleksandra, Sykutera, Monika, Bromińska, Barbara, Andrusiewicz, Mirosław, Ruchała, Marek, Sawicka-Gutaj, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046096/ https://www.ncbi.nlm.nih.gov/pubmed/36980552 http://dx.doi.org/10.3390/cancers15061665 |
Ejemplares similares
-
The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023) -
EZH2 and SMYD3 expression in papillary thyroid cancer
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021) -
Is eNAMPT/visfatin a potential serum marker of papillary thyroid
cancer?
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022) -
Changes of Nicotinamide Phosphoribosyltransferase Expressions in Thyroid Glands of Patients with Different Thyroid Pathologies
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2018) -
Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2015)